Thank you to all the speakers, chairs, attendees and organisers of the very first COG-UK Showcase Event: SARS-CoV-2 sequencing to inform clinical care, public health interventions and policy decisions.
The afternoon was filled with an array of thought-provoking talks, covering stimulating topics and research areas related to SARS-CoV-2 genome sequencing and what it has taught us to date about the ongoing COVID-19 pandemic.
The event featured an exceptional line-up of speakers, covering the focal themes of mutations and their implications for transmission, disease severity, therapeutics and vaccines; genomic-informed evidence on transmission in specific environments; and an overview of SARS-CoV-2 lineage introduction and transmission.
If you missed the live event, you can watch the full recording here.
COVID-19 Genomics UK (COG-UK)
The current COVID-19 pandemic, caused by the SARS-CoV-2, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.
Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and twelve academic partners providing sequencing and analysis capacity. A full list of collaborators can be found here: https://www.cogconsortium.uk/about/. Professor Peacock is also on a part-time secondment to PHE as Director of Science, where she focuses on the development of pathogen sequencing through COG-UK.
COG-UK was established in March 2020 supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation. For more information, visit: https://www.cogconsortium.uk